88. Onabotulinumtoxin-A improves chronic migraine: An open label, single-center, post-marketing prospective study

2015 ◽  
Vol 126 (1) ◽  
pp. e20
Author(s):  
F. Bianchi ◽  
B. Colombo ◽  
S. Amadio ◽  
R. Guerriero ◽  
C. Butera ◽  
...  
Keyword(s):  
Prospective Study ◽  
Chronic Migraine ◽  
Single Center ◽  
Open Label ◽  
Onabotulinumtoxin A ◽  
Post Marketing

scholarly journals Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study

Digestion ◽  
2016 ◽  
Vol 93 (3) ◽  
pp. 193-201 ◽  
Author(s):  
Shinya Sugimoto ◽  
Makoto Naganuma ◽  
Hiroki Kiyohara ◽  
Mari Arai ◽  
Keiko Ono ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Prospective Study ◽  
Clinical Efficacy ◽  
Efficacy And Safety ◽  
Single Center ◽  
Open Label

44. Onabotulinumtoxin-a treatment in chronic migraine: A long-term prospective open label study

2016 ◽  
Vol 127 (4) ◽  
pp. e142-e143
Author(s):  
C. Butera ◽  
F. Bianchi ◽  
S. Amadio ◽  
R. Guerriero ◽  
M. Cursi ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Onabotulinumtoxin A

scholarly journals An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Fayyaz Ahmed ◽  
◽  
Charly Gaul ◽  
Juan Carlos García-Moncó ◽  
Katherine Sommer ◽  
...  
Keyword(s):  
Prospective Study ◽  
Chronic Migraine ◽  
Real Life ◽  
Open Label ◽  
The Real
Sign in / Sign up

Export Citation Format

Share Document